M. Guyot

779 total citations
25 papers, 609 citations indexed

About

M. Guyot is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, M. Guyot has authored 25 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 8 papers in Psychiatry and Mental health and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in M. Guyot's work include Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). M. Guyot is often cited by papers focused on Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). M. Guyot collaborates with scholars based in France, United States and United Kingdom. M. Guyot's co-authors include P Loiseau, J. Hardenberg, Paul J. Schechter, M Pestre, Guy P. E. Tell, A Brendel, G. Lefort, G Manciet, Antoine Tabarin and Nathalie Valli and has published in prestigious journals such as NeuroImage, American Journal of Clinical Nutrition and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

M. Guyot

23 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Guyot France	13	219	218	192	131	110	25	609
Andrea Ernst Germany	14	166 0.8×	50 0.2×	18 0.1×	93 0.7×	88 0.8×	29	616
William A. Herzer United States	19	103 0.5×	34 0.2×	49 0.3×	64 0.5×	43 0.4×	45	786
Roger F. Butterworth Canada	14	53 0.2×	63 0.3×	42 0.2×	128 1.0×	84 0.8×	16	800
J A Lawson Australia	13	126 0.6×	30 0.1×	29 0.2×	33 0.3×	61 0.6×	18	613
Naruji Sugiyama Japan	18	64 0.3×	66 0.3×	237 1.2×	45 0.3×	68 0.6×	61	1.4k
B Astruc France	9	142 0.6×	78 0.4×	46 0.2×	47 0.4×	74 0.7×	21	689
Sten Christensen Denmark	18	68 0.3×	160 0.7×	73 0.4×	44 0.3×	31 0.3×	82	848
Shingo Ono Japan	13	28 0.1×	270 1.2×	90 0.5×	66 0.5×	63 0.6×	39	494
Alan Van Poznak United States	11	23 0.1×	87 0.4×	48 0.3×	78 0.6×	55 0.5×	28	559
Léo Berger Canada	10	69 0.3×	35 0.2×	30 0.2×	100 0.8×	18 0.2×	13	546

Countries citing papers authored by M. Guyot

Since Specialization

Citations

This map shows the geographic impact of M. Guyot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guyot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guyot more than expected).

Fields of papers citing papers by M. Guyot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Guyot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guyot. The network helps show where M. Guyot may publish in the future.

Co-authorship network of co-authors of M. Guyot

This figure shows the co-authorship network connecting the top 25 collaborators of M. Guyot. A scholar is included among the top collaborators of M. Guyot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Guyot. M. Guyot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergot, Emmanuel, Nicolas Elie, M. Guyot, et al.. (2025). NDR2 regulates non-small cell lung cancer cell migration under starvation by supporting autophagosome biogenesis through LC3 and ATG9A regulation. Cell Death Discovery. 12(1). 50–50.

Thibon, P., M. Guyot, Corinne Jeanne‐Pasquier, et al.. (2016). Practice of pathological examinations in stillbirths: A 10-year retrospective study. Journal of Gynecology Obstetrics and Human Reproduction. 46(1). 61–67. 4 indexed citations

Desbrée, Aurélie, et al.. (2015). Estimation personnalisée de la dose après totalisation isotopique par l’¹³¹I chez un patient présentant un goitre endothoracique résiduel. Radioprotection. 50(1). 11–17. 1 indexed citations

Vélayoudom‐Céphise, Fritz‐Line, Clément Morgat, Pauline M. Schwartz, et al.. (2015). Étude comparative de la TEP au 68Ga DOTATOC et de la tomoscintigraphie à l’111In-DTPA-octréotide pour le dépistage des tumeurs neuroendocrines duodénopancréatiques des patients porteurs d’une NEM1 : étude pilote. Annales d Endocrinologie. 76(4). 322–323. 1 indexed citations

Mazère, Joachim, Caroline Prunier, Olivier Barret, et al.. (2007). In vivo SPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease. NeuroImage. 40(1). 280–288. 47 indexed citations

Catargi, Bogdan, F Leprat, M. Guyot, et al.. (1999). Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome. European Journal of Endocrinology. 141(2). 117–121. 64 indexed citations

Valli, Nathalie, Bogdan Catargi, M. Guyot, et al.. (1999). Evaluation of Indium-111 Pentetreotide Somatostatin Receptor Scintigraphy to Detect Recurrent Thyroid Carcinoma in Patients with Negative Radioiodine Scintigraphy. Thyroid. 9(6). 583–589. 28 indexed citations

Sesay, M., et al.. (1996). Regional cerebral blood flow measurements with Xenon-CT in the prediction of delayed encephalopathy after carbon monoxide intoxication. Acta Neurologica Scandinavica. 93. 22–27. 12 indexed citations

Krempf, Michel, J. Lumbroso, R Mornex, et al.. (1991). Use ofm-[¹³¹I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 72(2). 455–461. 62 indexed citations

10.

Brendel, A, Bieke Lambert, M. Guyot, et al.. (1990). Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 16(1). 35–38. 48 indexed citations

11.

Brendel, A, et al.. (1988). Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma.. PubMed. 29(9). 1515–20. 51 indexed citations

12.

Loiseau, P, et al.. (1987). Incidence des crises épileptiques en Gironde.. Revue Neurologique. 143(5). 1 indexed citations

13.

Loiseau, P, et al.. (1987). [Incidence of epileptic seizures in Gironde].. PubMed. 143(5). 363–7. 2 indexed citations

14.

Loiseau, P, J. Hardenberg, M Pestre, et al.. (1986). Double‐Blind, Placebo‐Controlled Study of Vigabatrin (Gamma‐Vinyl GABA) in Drug‐Resistant Epilepsy. Epilepsia. 27(2). 115–120. 122 indexed citations

15.

Loiseau, P, et al.. (1985). [Carbamazepine poisoning caused by carbamazepine-erythromycin interaction].. PubMed. 14(3). 162–162. 5 indexed citations

16.

Levy, René H., et al.. (1984). Michaelis‐Menten Kinetics of Stiripentol in Normal Humans. Epilepsia. 25(4). 486–491. 30 indexed citations

17.

Guyot, M., et al.. (1983). [Pharmacokinetic study of apalcillin after infusion].. PubMed. 31(5). 319–22. 1 indexed citations

18.

Loiseau, P, et al.. (1983). Double‐Blind Crossover Trial of Progabide Versus Placebo in Severe Epilepsies. Epilepsia. 24(6). 703–715. 22 indexed citations

19.

Guyot, M., et al.. (1982). Liquid Chromatography Determination of Clobazam and Its Major Metabolite N-Desmethylclobazam in Human Plasma. Therapeutic Drug Monitoring. 4(3). 301–306. 18 indexed citations

20.

Ricour, C, et al.. (1977). Intestinal calcium-binding protein 3 months after massive small bowel resection in the piglet. American Journal of Clinical Nutrition. 30(12). 2041–2046. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact